Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Amortizatization of Intangibles (2021 - 2024)

Senti Biosciences (SNTI) has 4 years of Amortizatization of Intangibles data on record, last reported at $2.0 million in Q4 2024.

  • For Q4 2024, Amortizatization of Intangibles rose 317.63% year-over-year to $2.0 million; the TTM value through Dec 2024 reached $2.0 million, up 7.76%, while the annual FY2024 figure was $2.0 million, 7.76% up from the prior year.
  • Amortizatization of Intangibles reached $2.0 million in Q4 2024 per SNTI's latest filing, up from -$973000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.0 million in Q3 2022 and bottomed at -$1.7 million in Q4 2022.
  • Average Amortizatization of Intangibles over 4 years is $267692.3, with a median of $482000.0 recorded in 2023.
  • The widest YoY moves for Amortizatization of Intangibles: up 317.63% in 2024, down 308.35% in 2024.
  • A 4-year view of Amortizatization of Intangibles shows it stood at -$1.4 million in 2021, then decreased by 16.68% to -$1.7 million in 2022, then skyrocketed by 128.83% to $482000.0 in 2023, then skyrocketed by 317.63% to $2.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $2.0 million in Q4 2024, -$973000.0 in Q3 2024, and $973000.0 in Q2 2024.